These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 19584409)

  • 1. An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study.
    Collins GS; Altman DG
    BMJ; 2009 Jul; 339():b2584. PubMed ID: 19584409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.
    Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; May M; Brindle P
    BMJ; 2007 Jul; 335(7611):136. PubMed ID: 17615182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.
    Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; Minhas R; Sheikh A; Brindle P
    BMJ; 2008 Jun; 336(7659):1475-82. PubMed ID: 18573856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study.
    Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; Brindle P
    Heart; 2008 Jan; 94(1):34-9. PubMed ID: 17916661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study.
    Collins GS; Altman DG
    BMJ; 2010 May; 340():c2442. PubMed ID: 20466793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2.
    Collins GS; Altman DG
    BMJ; 2012 Jun; 344():e4181. PubMed ID: 22723603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study.
    Hippisley-Cox J; Coupland C; Brindle P
    BMJ; 2013 May; 346():f2573. PubMed ID: 23641033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database.
    Hippisley-Cox J; Coupland C; Robson J; Brindle P
    BMJ; 2010 Dec; 341():c6624. PubMed ID: 21148212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the ASSIGN cardiovascular disease risk score on a UK cohort of patients from general practice.
    de la Iglesia B; Potter JF; Poulter NR; Robins MM; Skinner J
    Heart; 2011 Mar; 97(6):491-9. PubMed ID: 21097820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore.
    Hippisley-Cox J; Coupland C; Robson J; Sheikh A; Brindle P
    BMJ; 2009 Mar; 338():b880. PubMed ID: 19297312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
    Hippisley-Cox J; Coupland C; Brindle P
    BMJ; 2017 May; 357():j2099. PubMed ID: 28536104
    [No Abstract]   [Full Text] [Related]  

  • 12. Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and Framingham scores in a U.K. tri-ethnic prospective cohort study (SABRE--Southall And Brent REvisited).
    Tillin T; Hughes AD; Whincup P; Mayet J; Sattar N; McKeigue PM; Chaturvedi N;
    Heart; 2014 Jan; 100(1):60-7. PubMed ID: 24186564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease.
    Ganz P; Heidecker B; Hveem K; Jonasson C; Kato S; Segal MR; Sterling DG; Williams SA
    JAMA; 2016 Jun; 315(23):2532-41. PubMed ID: 27327800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study.
    Davis WA; Colagiuri S; Davis TM
    Med J Aust; 2009 Feb; 190(4):180-4. PubMed ID: 19220181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation and clinical usefulness of three commonly used cardiovascular risk prediction scores in an Emirati population: a retrospective longitudinal cohort study.
    Al-Shamsi S; Govender RD; King J
    BMJ Open; 2020 Oct; 10(10):e040680. PubMed ID: 33115904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10.
    Riddell T; Wells S; Jackson R; Lee AW; Crengle S; Bramley D; Ameratunga S; Pylypchuk R; Broad J; Marshall R; Kerr A
    N Z Med J; 2010 Feb; 123(1309):50-61. PubMed ID: 20186242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study.
    Albarqouni L; Doust JA; Magliano D; Barr EL; Shaw JE; Glasziou PP
    Med J Aust; 2019 Mar; 210(4):161-167. PubMed ID: 30656697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the risk of chronic Kidney Disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores.
    Hippisley-Cox J; Coupland C
    BMC Fam Pract; 2010 Jun; 11():49. PubMed ID: 20565929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marginal role for 53 common genetic variants in cardiovascular disease prediction.
    Morris RW; Cooper JA; Shah T; Wong A; Drenos F; Engmann J; McLachlan S; Jefferis B; Dale C; Hardy R; Kuh D; Ben-Shlomo Y; Wannamethee SG; Whincup PH; Casas JP; Kivimaki M; Kumari M; Talmud PJ; Price JF; Dudbridge F; Hingorani AD; Humphries SE;
    Heart; 2016 Oct; 102(20):1640-7. PubMed ID: 27365493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of the Framingham and SCORE cardiovascular risk prediction functions in a non-diabetic population of a Spanish health care centre: a validation study.
    Barroso LC; Muro EC; Herrera ND; Ochoa GF; Hueros JI; Buitrago F
    Scand J Prim Health Care; 2010 Dec; 28(4):242-8. PubMed ID: 20873973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.